Baselli, G. A. et al. performed whole-exome sequencing for 301 patients with NAFLD and showed enriched variants of ATG7 rs143545741 p.V471A and p.P426L (loss-of-function mutation) in patients with advanced fibrosis [107]. This evidence concerns the gene ATG7 and metabolic dysfunction-associated steatotic liver disease.